Literature DB >> 34779914

Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson's disease: mutational spectrum and clinical features.

Jia Lun Lim1,2, Katja Lohmann3, Ai Huey Tan2,4, Yi Wen Tay1,2, Khairul Azmi Ibrahim5, Zariah Abdul Aziz5, Ahmad Shahir Mawardi6, Santhi Datuk Puvanarajah6, Thien Thien Lim7,8, Irene Looi9, Joshua Chin Ern Ooi10, Yuen Kang Chia10, Kalai Arasu Muthusamy11, Peter Bauer12, Arndt Rolfs12, Christine Klein3, Azlina Ahmad-Annuar13, Shen-Yang Lim14,15.   

Abstract

GBA variants are associated with increased risk and earlier onset of Parkinson's disease (PD), and more rapid disease progression especially with "severe" variants typified by p.L483P. GBA mutation screening studies from South-East Asia, with > 650 million inhabitants of diverse ancestries, are very limited. We investigated the spectrum of GBA variants, and associated clinico-demographic features, in a multi-ethnic PD cohort in Malaysia. Patients (n = 496) were recruited from seven centres, primarily of Chinese (45%), Malay (37%), and Indian (13%) ethnicities. All GBA coding exons were screened using a next-generation sequencing-based PD gene panel and verified with Sanger sequencing. We identified 14 heterozygous GBA alleles consisting of altogether 17 missense variants (8 classified as pathogenic or likely pathogenic for PD) in 25 (5.0%) patients, with a substantially higher yield among early (< 50 years) vs. late-onset patients across all three ethnicities (9.1-13.2% vs. 1.0-3.2%). The most common variant was p.L483P (including RecNciI, n = 11, 2.2%), detected in all three ethnicities. Three novel variants/recombinant alleles of uncertain significance were found; p.P71L, p.L411P, and p.L15S(;)S16G(;)I20V. The common European risk variants, p.E365K, p.T408M, and p.N409S, were not detected. A severe disease course was noted in the majority of GBA-variant carriers, across a range of detected variants. We report a potentially novel observation of spine posture abnormalities in GBA-variant carriers. This represents the largest study on GBA variation from South-East Asia, and highlights that these populations, especially those with EOPD, would be relevant for studies including clinical trials targeting GBA pathways.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Camptocormia; Early-onset PD; GBA; Genetics; Parkinson’s disease

Mesh:

Substances:

Year:  2021        PMID: 34779914     DOI: 10.1007/s00702-021-02421-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

1.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Agnes P Chan
Journal:  Bioinformatics       Date:  2015-04-06       Impact factor: 6.937

2.  Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Authors:  R N Alcalay; E Caccappolo; H Mejia-Santana; M -X Tang; L Rosado; M Orbe Reilly; D Ruiz; B Ross; M Verbitsky; S Kisselev; E Louis; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; H Andrews; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Rezak; K Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; A Siderowf; H Payami; E Molho; S Factor; R Ottman; L N Clark; K Marder
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

3.  Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.

Authors:  Jung Mi Choi; Won Chan Kim; Chul Hyoung Lyoo; Suk Yun Kang; Phil Hyu Lee; Jong Sam Baik; Seong-Beom Koh; Hyeo-Il Ma; Young Ho Sohn; Myung Sik Lee; Yun Joong Kim
Journal:  Neurosci Lett       Date:  2012-02-22       Impact factor: 3.046

4.  Identification of GBA mutations among neurodegenerative disease patients from eastern India.

Authors:  Arindam Biswas; Dipanwita Sadhukhan; Atanu Biswas; Shyamal K Das; Tapas K Banerjee; Partha Sarathi Bal; Sandip Pal; Amitabha Ghosh; Kunal Ray; Jharna Ray
Journal:  Neurosci Lett       Date:  2021-03-09       Impact factor: 3.046

5.  GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.

Authors:  Kathrin Brockmann; Karin Srulijes; Sylvia Pflederer; Ann-Kathrin Hauser; Claudia Schulte; Walter Maetzler; Thomas Gasser; Daniela Berg
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

Review 6.  Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.

Authors:  Byron Creese; Emily Bell; Iskandar Johar; Paul Francis; Clive Ballard; Dag Aarsland
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-05-26       Impact factor: 3.568

Review 7.  The genetic architecture of Parkinson's disease.

Authors:  Cornelis Blauwendraat; Mike A Nalls; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-09-11       Impact factor: 44.182

8.  Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.

Authors:  Roberto Cilia; Sara Tunesi; Giorgio Marotta; Emanuele Cereda; Chiara Siri; Silvana Tesei; Anna L Zecchinelli; Margherita Canesi; Claudio B Mariani; Nicoletta Meucci; Giorgio Sacilotto; Michela Zini; Michela Barichella; Corrado Magnani; Stefano Duga; Rosanna Asselta; Giulia Soldà; Agostino Seresini; Manuela Seia; Gianni Pezzoli; Stefano Goldwurm
Journal:  Ann Neurol       Date:  2016-10-03       Impact factor: 10.422

Review 9.  Parkinson's disease.

Authors:  Bastiaan R Bloem; Michael S Okun; Christine Klein
Journal:  Lancet       Date:  2021-04-10       Impact factor: 79.321

10.  Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Authors:  Cornelis Blauwendraat; Xylena Reed; Lynne Krohn; Karl Heilbron; Sara Bandres-Ciga; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Ravindran Kumaran; Rebekah Langston; Luis Bonet-Ponce; Roy N Alcalay; Sharon Hassin-Baer; Lior Greenbaum; Hirotaka Iwaki; Hampton L Leonard; Francis P Grenn; Jennifer A Ruskey; Marya Sabir; Sarah Ahmed; Mary B Makarious; Lasse Pihlstrøm; Mathias Toft; Jacobus J van Hilten; Johan Marinus; Claudia Schulte; Kathrin Brockmann; Manu Sharma; Ari Siitonen; Kari Majamaa; Johanna Eerola-Rautio; Pentti J Tienari; Alexander Pantelyat; Argye E Hillis; Ted M Dawson; Liana S Rosenthal; Marilyn S Albert; Susan M Resnick; Luigi Ferrucci; Christopher M Morris; Olga Pletnikova; Juan Troncoso; Donald Grosset; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Alastair J Noyce; Eliezer Masliah; Nick Wood; John Hardy; Lisa M Shulman; Joseph Jankovic; Joshua M Shulman; Peter Heutink; Thomas Gasser; Paul Cannon; Sonja W Scholz; Huw Morris; Mark R Cookson; Mike A Nalls; Ziv Gan-Or; Andrew B Singleton
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more
  2 in total

Review 1.  Psychosis in Parkinson's Disease: A Lesson from Genetics.

Authors:  Efthalia Angelopoulou; Anastasia Bougea; Sokratis G Papageorgiou; Chiara Villa
Journal:  Genes (Basel)       Date:  2022-06-20       Impact factor: 4.141

Review 2.  Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.

Authors:  Fangzhi Jia; Avi Fellner; Kishore Raj Kumar
Journal:  Genes (Basel)       Date:  2022-03-07       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.